轩竹生物科技股份有限公司

Country

Ownership: -

Established: 2018-09-05

Employees: -

Market Cap: -

Website: www.xuanzhubio.com

Clinical Trials

0

Active:0

Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Bireociclib Tablets

Product Name: 轩悦宁

Approval Number: 国药准字H20250013

Approval Date: May 13, 2025

NMPA

Fulvestrant Injection

Product Name: 氟维司群注射液

Approval Number: 国药准字H20243158

Approval Date: Feb 6, 2024

NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.